A chondroitin sulfate proteoglycan 4-specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model

The overexpression of chondroitin sulfate proteoglycan 4 (CSPG4) is associated with several tumor types, including malignant melanoma, squamous cell carcinoma, triple-negative breast carcinoma, oligodendrocytomas or gliomas. Due to its restricted distribution in normal tissues, CSPG4 has been consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Uranowska, Karolina, Samadaei, Mahzeiar, Kalic, Tanja, Pinter, Matthias, Breiteneder, Heimo, Hafner, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357264/
https://www.ncbi.nlm.nih.gov/pubmed/34318902
http://dx.doi.org/10.3892/ijo.2021.5250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357264/
https://www.ncbi.nlm.nih.gov/pubmed/34318902
http://dx.doi.org/10.3892/ijo.2021.5250

Ejemplares similares